depression from semaglutide is associated with a 44% decreased risk of and a 38% decreased risk of anxiety 🔗 Click the link in our bio to read the full story Weight loss jabs may help

Though initially approved in 2017 to help manage diabetes, the FDA authorized its use for weight management in non-diabetic individuals in 2021

Retrieved June 11, 2025, from Swiss Medica

Our independent providers offer dedicated care and competitive pricing

Common adverse effects include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation

16 The researchers note that ozempic and HRT might share mutual benefits because of the room for improvement in insulin resistance, as well as for lifestyle reasons

The Observational Health Data Sciences and Informatics (OHDSI) network conducted an expansive analysis encompassing 37.1 million adults with Type 2 diabetes across 14 international databases, published in February 2025